Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets. (American journal of pathology, 2013)

(untitled) - van Oosterwijk, J; Meijer, D; Ruler, v; van den Akker, B; Oosting, J; Krenács, T; Picci, P; Flanagan, A; Liegl-Atzwanger, B; Leithner, A; Athanasou, N; Daugaard, S; et al.